Setting up a primary aldosteronism program:an Australian experience

VernacularTitle:建立原发性醛固酮增多症诊疗的程序——澳大利亚的经验介绍
Author: Yang JUN ¹ ; John W Funder AC ; Shi CHEN ; Zhengpei ZENG
Author Information

1. 澳大利亚
Keywords: Aldosterone; Hypertension; Spironolactone; Adrenal
From:Chinese Journal of Endocrinology and Metabolism 2018;34(6):451-459
CountryChina
Language:Chinese
Abstract: The year after aldosterone was isolated and characterized, primary aldosteronism ( PA) was recognised as causing hypokalemia and hypertension, in response to hormone secretion inappropriate for sodium levels. This manuscript deals with three time periods since then: the first sixty five years, its current management in a very active clinic in Melbourne, Australia; and finally some suggestions as to improvements in recognition, diagnosis and management over the next five years. We will suggest improvements that endocrinologists, in China and elsewhere, might consider for what has emerged as a major public health issue.